Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer

Abstract Background We examined real-world outcomes of patients with metastatic hormone-sensitive prostate cancer (mHSPC) treated with apalutamide plus androgen deprivation therapy (ADT). The current study, reflecting real-life practice, included specific subpopulations not evaluated in the pivotal...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin Boegemann, Mostefa Bennamoun, Louis Marie Dourthe, Juan Antonio Encarnacion, Axel Hegele, Eva Hellmis, Igor Latorzeff, Wolfgang Leicht, Julián Oñate-Celdrán, Antonio Rosino-Sánchez, Krystelle Hanna, Joana Lencart, Martin Lukac, Claudio A. Schioppa, Suzy Van Sanden, Gero Kramer
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Apalutamide
Metastatic hormone-sensitive prostate cancer
Prostate-specific antigen
Online Access:https://doi.org/10.1186/s12885-025-14294-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items